Amancer Medicament Private Limited
About Amancer Medicament Private Limited
Data last updated:
Amancer Medicament Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 09 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2018PTC102890.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Anamika Devi and Anup Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gorakhpur, Uttar Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹12.5 Lakh, a growth of 39% compared to the previous year. For the same year it recorded a net loss of ₹21,523 (net margin -1.7%) and EBITDA of -₹21,523 (EBITDA margin -1.7%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.N. 251E Kharaiya Pokhra, Ashok Nagar, Gorakhpur, Uttar Pradesh, India – 273006
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Amancer Medicament Private Limited
The main business activity of Amancer Medicament is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Amancer Medicament Private Limited FY 2025 filings available
Amancer Medicament Private Limited reported revenue of ₹12.5 Lakh (up 39% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Amancer Medicament Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 35% over three years, including 39% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Amancer Medicament Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹21,523 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹21,523 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Amancer Medicament Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amancer Medicament are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Amancer Medicament Private Limited
Amancer Medicament has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anamika Devi | Director | 09 Apr 2018 | 8 Years 6 Months | Current |
| Anup Kumar Srivastava | Director | 09 Apr 2018 | 8 Years 6 Months | Current |
Peer Comparison of Amancer Medicament Private Limited
Amancer Medicament Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nutragenesis Private Limited | ₹12.5 Lakh (FY 2021) | •••• | •••• | -11.0% | •••• | Mumbai, Maharashtra, India |
| Ubantu Foundation | ₹12.5 Lakh (FY 2025) | •••• | •••• | 38.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Relix International Private Limited | ₹12.5 Lakh (FY 2022) | •••• | •••• | •••• | Rajkot, Gujarat, India | |
| Amexx Clothing Private Limited | ₹12.5 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | New Delhi, Delhi, India |
| Orbit Merchandise Pvt Ltd | ₹12.5 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Kolkata, West Bengal, India |
| Amancer Medicament Private Limited this company | ₹12.5 Lakh (FY 2024) | •••• | •••• | 39.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Bhayana Electronic Industries Private Limited | ₹12.49 Lakh (FY 2024) | •••• | •••• | -7.0% | •••• | New Delhi, Delhi, India |
| Norin Business Network Private Limited | ₹12.49 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Coimbatore, Tamil Nadu, India |
| Pickle Yolk Books (OPC) Private Limited | ₹12.49 Lakh (FY 2025) | •••• | •••• | 73.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Kalinjar Naraini Farmer Producer Company Limited | ₹12.49 Lakh (FY 2025) | •••• | •••• | 364.0% | •••• | Banda, Uttar Pradesh, India |
| Parakh Spinners Private Limited | ₹12.49 Lakh (FY 2024) | •••• | •••• | 174.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Amancer Medicament by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Amancer Medicament Private Limited
Amancer Medicament Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Amancer Medicament Private Limited
Employment history and EPFO contributions of people linked to Amancer Medicament.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Amancer Medicament Private Limited
Amancer Medicament Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Anamika Devi was appointed as Director on 09 Apr 2018.
Credit Ratings, Litigation & Regulatory Alerts for Amancer Medicament Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Amancer Medicament Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amancer Medicament Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amancer Medicament Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amancer Medicament Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amancer Medicament Private Limited
Amancer Medicament is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 09 April 2018 (8+ years old) and is registered under CIN U51909UP2018PTC102890.
Amancer Medicament reported revenue of ₹12.5 Lakh for FY 2024 (up 39% YoY).
Amancer Medicament has 2 current directors:
- Anamika Devi - Director
- Anup Kumar Srivastava - Director
Amancer Medicament reported a net loss of ₹21,523 (net margin -1.7%) and EBITDA of -₹21,523 (EBITDA margin -1.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Amancer Medicament is 35% over three years. In the latest year (FY 2024) revenue rose 39%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Amancer Medicament is U51909UP2018PTC102890. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amancer Medicament was incorporated on 09 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Amancer Medicament by revenue are Nutragenesis Private Limited, Ubantu Foundation, Relix International Private Limited, Amexx Clothing Private Limited, Orbit Merchandise Pvt Ltd and 5 more, all in the same principal business activity (Wholesale Trading).
Anamika Devi was appointed as Director on 09 Apr 2018. Anup Kumar Srivastava was appointed as Director on 09 Apr 2018.
The registered office of Amancer Medicament is at H.N. 251E Kharaiya Pokhra, Ashok Nagar, Gorakhpur, Uttar Pradesh, India – 273006.
Amancer Medicament has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh.